Elaine D. Sun
2020
In 2020, Elaine D. Sun earned a total compensation of $3.4M as Senior Vice President Chief Financial Officer at Halozyme Therapeutics.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $180,352 |
| Option Awards | $1,000,008 |
| Salary | $395,833 |
| Stock Awards | $1,500,269 |
| Other | $133,399 |
| Total | $3,359,861 |
Sun received $1.5M in stock awards, accounting for 45% of the total pay in 2020.
Sun also received $150K in bonus, $180.4K in non-equity incentive plan, $1M in option awards, $395.8K in salary and $133.4K in other compensation.
Rankings
In 2020, Elaine D. Sun's compensation ranked 3,459th out of 13,090 executives tracked by ExecPay. In other words, Sun earned more than 73.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,459 out of 13,090 | 74th |
Division Manufacturing | 1,348 out of 5,620 | 76th |
Major group Chemicals And Allied Products | 508 out of 2,253 | 78th |
Industry group Drugs | 441 out of 1,953 | 77th |
Industry Biological Products, Except Diagnostic Substances | 108 out of 411 | 74th |
Pay ratio
| Elaine D. Sun's Pay | $3,359,861 |
|---|---|
| Median Employee's Pay | $223,441 |
| Pay Ratio | 15to 1 |
In 2020, the annual total compensation of Elaine D. Sun was $3,359,861.
The annual total compensation of the median employee at Halozyme Therapeutics was $223,441.
The ratio of Elaine D. Sun's pay to the pay of median employee was therefore 15 to one.
Source: SEC filing on March 26, 2021.
Sun's colleagues
We found four more compensation records of executives who worked with Elaine D. Sun at Halozyme Therapeutics in 2020.